Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Application of nanotechnology in food science, processing and packaging / / Chukwuebuka Egbuna [and three others], editors
| Application of nanotechnology in food science, processing and packaging / / Chukwuebuka Egbuna [and three others], editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer Nature Switzerland AG, , [2022] |
| Descrizione fisica | 1 online resource (266 pages) |
| Disciplina | 664 |
| Soggetto topico |
Food
Food industry and trade Nanotechnology |
| ISBN | 3-030-98820-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910568241703321 |
| Cham, Switzerland : , : Springer Nature Switzerland AG, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dietary phytochemicals : a source of novel bioactive compounds for the treatment of obesity, cancer and diabetes / / Chukwuebuka Egbuna, Sadia Hassan, editors
| Dietary phytochemicals : a source of novel bioactive compounds for the treatment of obesity, cancer and diabetes / / Chukwuebuka Egbuna, Sadia Hassan, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (262 pages) |
| Disciplina | 615.321 |
| Soggetto topico |
Phytochemicals - Health aspects
Fitoquímica Nutrició Biotransformació (Metabolisme) Càncer Obesitat Diabetis |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-72999-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Etiology of Obesity, Cancer, and Diabetes -- 1 Introduction -- 2 Obesity -- 2.1 Etiology of Obesity -- 2.2 Biological Factors -- 2.2.1 Genetics -- Monogenic Obesity -- Syndromic Obesity -- Polygenic Obesity -- 2.2.2 Brain-gut Axis -- 2.2.3 Prenatal Determinants -- 2.2.4 Pregnancy -- 2.2.5 Menopause -- 2.2.6 Physical Disability -- 2.2.7 Gut Microbiome -- 2.3 Environmental Factors -- 2.3.1 Obesogenic Environment -- 2.3.2 Socio-Economic Factors -- 2.3.3 Environmental Chemicals and Obesity -- 2.4 Behavioral Factors -- 2.4.1 Increased Calorie Intake and Eating Habits -- 2.4.2 Sedentary Lifestyle and Less Physical Activity -- 2.4.3 Insufficient Sleep -- 2.4.4 Quitting Smoking -- 3 Cancer -- 3.1 Major Types of Cancer -- 3.2 Causes of Cancer -- 3.2.1 Diet and Physical Activity -- 3.2.2 Use of Addictive Substances -- 3.2.3 Sex and Reproductive Health -- 3.2.4 Environmental Factors -- 3.2.5 Genetics -- 4 Diabetes Mellitus -- 4.1 Causes of Type 1 Diabetes Mellitus -- 4.1.1 Genetic Susceptibility Factors -- 4.1.2 Virus-Related Contagions -- 4.1.3 Role of Environment -- 4.2 Etiology of Type 2 Diabetes Mellitus -- 5 Conclusion -- References -- Pathophysiology of Obesity and Diabetes -- 1 Introduction -- 2 Obesity and Body Mass Index -- 3 Pathophysiology of Obesity -- 3.1 Development of Fat Cells -- 3.2 Fat Cell Metabolism -- 3.3 Oxidative Stress -- 3.4 Weight Stigma -- 4 Role of Different Factors in the Pathophysiology of Obesity -- 4.1 Pathophysiology of Obesity and the Role of Autonomic Nervous System -- 4.2 Osteopontin and Obesity -- 4.3 Obesity and Renal Disease -- 5 Maternal Obesity -- 6 Potential Role of Gut Inflammation in Disease Development -- 7 Childhood Obesity -- 8 Pathophysiology of Diabetes -- 8.1 Etiology of Diabetes -- 8.2 Role of Genetics in Development of T2DM.
8.3 Role of Environmental Determinants in the Development of T2DM -- 8.4 Insulin Resistance -- 8.5 The Role of Glucagon -- 8.6 Somatostatin -- 9 Conclusion -- References -- Pathophysiology of Obesity and Cancer: Drugs and Signaling Targets -- 1 Introduction -- 2 Pathophysiology of Obesity and Cancer -- 3 History of Anti-obesity Drugs -- 4 How to Treat Obesity? -- 5 Different Targets in Brain to Treat Obesity -- 5.1 Serotoninergic System -- 5.2 Noradrenergic System -- 5.3 Dopaminergic System -- 6 Link Between Obesity and Cancer -- 7 Drugs Targeting Cancer Cells -- 8 Drugs Targeting the Tumor Microenvironment's Cellular and Molecular Components -- 9 Changes in the Pharmacokinetics -- 10 Changes in Microbiota -- 11 Combination Therapy -- 12 Conclusion -- References -- Peptides Involved in Body Weight Regulation -- 1 Introduction -- 2 Appetite, Food Intake, and Obesity -- 3 Peptides and Body Weight -- 3.1 Effects of Hormonal Peptides -- 3.1.1 Orexigenic Peptides -- 3.1.2 Anorexigenic Peptides -- 3.1.3 Effects of Hypothalamic Peptides -- 3.2 Bioactive Peptides and Body Weight -- 4 Conclusion -- References -- Insulin Resistance: A Link Between Obesity and Cancer -- 1 Introduction -- 2 Obesity and Cancer -- 3 Diabetes and Cancer -- 4 Obesity and Diabetes -- 5 Mechanism Linking Insulin Resistance to Obesity and Cancer -- 6 Drugs to Treat Insulin Resistance -- 6.1 Metformin -- 6.2 Thiazolidinediones -- 6.3 Insulin Analogues -- 7 Challenges in Prevention and Treatment -- 8 Conclusion -- References -- Role of Cytoskeletal Protein, Actin in Various Diseases -- 1 Introduction -- 2 Microfilaments or Actin Filaments -- 2.1 Role in Cancer Metastasis and Tumor Angiogenesis -- 2.2 Role in Cytokinesis -- 2.3 Role in Cellular Signaling and Transport -- 2.4 Role in Immunodeficiency -- 2.5 Role in Fertilization of Eggs -- 2.6 Role in Neuronal Plasticity. 2.7 Role in Neurodegenerative Diseases -- 2.8 Role in Epigenetic Control -- 2.9 Role in Muscle Contraction -- 3 Conclusions -- References -- Diabetes Mellitus and it Management with Plant-Based Therapy -- 1 Introduction -- 2 Classification of Diabetes -- 2.1 Type I Diabetes Mellitus (T1DM) -- 2.2 Type II Diabetes Mellitus (T2DM) -- 2.3 Gestational DM (GDM) -- 3 Risk Factors of Diabetes -- 4 Pathophysiology -- 5 Screening and Diagnosis -- 6 Management -- 6.1 Through Lifestyle and Diet Modification -- 6.2 Pharmacological Agents -- 6.3 Plant Based Therapy -- 6.3.1 Mechanisms Underlying Herbal Anti-Diabetic Therapies -- 6.3.2 Classification of Plant-Based Anti-Diabetics -- 7 Conclusion -- References -- Fruits and Vegetables as Sources of Functional Phytochemicals for the Prevention and Management of Obesity, Diabetes, and Cancer -- 1 Introduction -- 2 Classification of Phytochemicals -- 2.1 Polyphenols -- 2.2 Terpenoids -- 2.3 Thiols -- 3 Health Benefits and Nutritional Value of Certain Fruits and Vegetables -- 3.1 Tomatoes -- 3.2 Grapes and Berries -- 3.3 Nuts -- 3.4 Citrus -- 3.5 Brassica Vegetables -- 3.6 Mushrooms -- 3.7 Kiwi -- 3.8 Cladodes -- 3.9 Carrots -- 3.10 Potatoes -- 3.11 Onion and Garlic -- 4 The Effect of Consuming Fruits and Vegetables on Some Diseases -- 4.1 Cancer -- 4.2 Obesity -- 4.3 Diabetes -- 5 Conclusion -- References -- Spices for Diabetes, Cancer and Obesity Treatment -- 1 Introduction -- 2 Anti-diabetic Effect of Spices -- 2.1 Fenugreek -- 2.2 Cinnamon -- 2.3 Garlic and Onion -- 2.4 Turmeric -- 2.5 Cumin Seeds -- 2.6 Ginger -- 3 Spices in the Treatment of Cancer -- 3.1 Basil -- 3.2 Caraway -- 3.3 Cardamom -- 3.4 Rosemary -- 3.5 Cumin -- 3.6 Turmeric -- 3.7 Garlic -- 3.8 Black Pepper -- 3.9 Red Chili -- 3.10 Ginger -- 3.11 Saffron -- 4 Spices in the Treatment of Obesity -- 4.1 Ginger -- 4.2 Turmeric -- 4.3 Garlic. 4.4 Red Pepper -- 5 Conclusion -- References -- MicroRNAs as Targets of Dietary Phytochemicals in Obesity and Cancer -- 1 Introduction -- 2 Phytochemical Modulated miRNAs and Its Role in Obesity -- 3 MicroRNAs as Phytochemicals Targets in Carcinogenesis -- 4 Dietary Phytochemicals and miRNA -- 4.1 Resveratrol -- 4.2 Genistein -- 4.3 Conjugated Linoleic Acids -- 4.4 Cinnamic Acid and Cinnamaldehyde -- 4.5 Ajoene -- 4.6 Curcumin -- 4.7 Epigallocatechin-3-Gallate -- 4.8 Quercetin -- 5 Conclusion -- References -- Natural Phenolic Compounds as Anti-obesity and Anti-cardiovascular Disease Agent -- 1 Introduction -- 2 Effects of Natural Phenolic Compounds on Oil and Fat Metabolism -- 3 Binding Bile Salt to Inhibit Emulsification of Lipids -- 3.1 In Vitro Studies -- 4 Pancreatic Lipase Inhibition -- 4.1 In Vitro Studies -- 4.2 In Silico Modeling Studies -- 4.3 Increase Fecal Lipid Excretion -- 4.4 Animal Models -- 4.5 Clinical Research -- 5 Gut Microbiota as Potential Targets -- 6 Reduction of Lipogenesis and Inflammation in Adipose Tissue and Liver -- 6.1 In Vitro Studies by Cell Models -- 6.2 Animal Models -- 7 Suppression of Lipogenic Enzyme Fatty Acid Synthase (FAS) in Cell -- 7.1 Cell Model -- 7.2 Animal Models -- 8 Increase of Lipolysis in Cell -- 9 Inhibition of Adipocyte Differentiation and Growth -- 10 Anti-atherosclerosis by Natural Phenolic Compounds -- 11 Conclusion -- References -- Harnessing the Potential of Phytochemicals for Breast Cancer Treatment -- 1 Introduction -- 2 Statistical Evidence Including the Indian Scenario -- 3 Current Treatments Strategies for Breast Cancer -- 3.1 Chemotherapy -- 3.2 Surgery -- 3.3 Gene Therapy -- 3.4 Oncogenes Inactivation -- 3.5 Augmentation of Tumor Suppresser Genes -- 3.5.1 BRCA1 and BRCA2 -- 3.5.2 Androgen Receptor -- 3.5.3 Immunomodulation -- 3.5.4 Endocrine (Antihormonal) Treatment. 3.5.5 Inclination Towards Phytochemicals -- 4 Phytochemicals for Breast Cancer Therapy -- 4.1 Plumbagin -- 4.2 Apigenin -- 4.3 Isothiocyanate -- 4.4 Quercetin -- 4.5 Curcumin -- 4.6 Catechins -- 4.7 Lycopene -- 4.8 Hesperidin -- 4.9 Anthocyanin -- 4.10 Colchicine Alkaloid -- 4.11 Polyphyllin D -- 4.12 Genistein -- 4.13 Resveratrol -- 4.14 Berberine -- 5 Pharmaceutical Compounding of Phytochemicals -- 6 Conclusion -- References -- Index. |
| Record Nr. | UNINA-9910495214003321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Food and agricultural byproducts as important source of valuable nutraceuticals / / Chukwuebuka Egbuna, Barbara Sawicka, Johra Khan, editors
| Food and agricultural byproducts as important source of valuable nutraceuticals / / Chukwuebuka Egbuna, Barbara Sawicka, Johra Khan, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (257 pages) |
| Disciplina | 664 |
| Soggetto topico |
Food waste - Recycling
Functional foods |
| ISBN | 3-030-98760-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910584479303321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Functional Foods and Nutraceuticals : Bioactive Components, Formulations and Innovations / / edited by Chukwuebuka Egbuna, Genevieve Dable Tupas
| Functional Foods and Nutraceuticals : Bioactive Components, Formulations and Innovations / / edited by Chukwuebuka Egbuna, Genevieve Dable Tupas |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (642 pages) |
| Disciplina | 613.2 |
| Soggetto topico |
Food—Biotechnology
Nutrition Microbiology Food Science Nutrition Food Microbiology |
| ISBN | 3-030-42319-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Foreword -- Preface -- Part I: Introduction to functional foods and nutraceuicals -- Chapter 1: Functional foods and health benefits -- Chapter 2: Bioavailability of Nutrients and Safety Measurements -- Part II: Components of functional foods -- Chapter 3: Polyphenols and carotenoids as functional Bioactives -- Chapter 4: Bioactive carbohydrates and sources -- Chapter 5: Bioactive peptides and sources -- Chapter 6: Fats and oils as sources of bioactive molecules -- Chapter 7: Micronutrients fortifications: Vitamins and minerals -- Chapter 8: Usefulness of prebiotics, probiotics, and synbiotics in improving health status -- Chapter 9: Cereals and grains as functional food in Unani system of medicine -- Chapter 10: Soya beans and other plant protein products -- Chapter 11: Honey., Chapter 12: Mushrooms -- Chapter 13: Beverages: Cocoa and other caffeine products -- Chapter 14: Milk and milk products -- Chapter 15: Fruits and vegetables -- Chapter 16: Fish and fish products -- Chapter 17: Medical foods and infant formulas -- Part III: Safety Concerns and way forward -- Chapter 18: Nutraceutical stability, adulteration and way forward -- Chapter 19: Good manufacturing practices and safety issues in functional food industries -- Chapter 20: Food preservation concerns. |
| Record Nr. | UNINA-9910416140903321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Handbook of Agricultural Biotechnology, Volume 5 : Nanobiofertilizers
| Handbook of Agricultural Biotechnology, Volume 5 : Nanobiofertilizers |
| Autore | Adetunji Charles Oluwaseun |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Newark : , : John Wiley & Sons, Incorporated, , 2024 |
| Descrizione fisica | 1 online resource (595 pages) |
| Altri autori (Persone) |
EgbunaChukwuebuka
FicaiAnton IjabadeniyiOluwatosin Ademola |
| Collana | Handbook of Agricultural Bionanobiotechnology Series |
| ISBN |
1-394-21154-6
1-394-21152-X 1-394-21153-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- Chapter 1 Application of Nanobiofertilization for Bioremediation and Ecorestoration of Polluted Soil/Farmland -- 1.1 Introduction -- 1.2 Nanoparticles -- 1.2.1 Nanoparticles as Nano-Adsorbents -- 1.2.2 Nanobiofertilizers -- 1.2.3 Biosynthesis of Nanoparticles -- 1.2.4 Microbe-Mediated Synthesis -- 1.2.5 Plant-Mediated Synthesis -- 1.3 Nanobiofertilization in Bioremediation -- 1.3.1 Mechanism of NPs-Microbes Interaction in Pollutant Bioremediation -- 1.3.2 Plant and Nanoparticle-Based Interaction Mechanism in Pollutant Bioremediation -- 1.4 Application of Nanobiofertilization in Bioremediation -- 1.4.1 Heavy Metals Removal -- 1.4.2 Removal of Hydrocarbon -- 1.4.3 Removal of Colored Dyes -- 1.4.4 Removal of Antiseptics and Antibiotics -- 1.4.5 Nano-Phytoremediation of Polluted Soils -- 1.4.6 Removal of Organic Pollutants -- 1.4.7 Removal of Heavy Metal -- 1.5 Environmental Distress -- 1.6 Conclusion -- References -- Chapter 2 Influence of Nanobiofertilizer on Plant Yield and Growth -- 2.1 Introduction -- Nanobiofertilizer -- Composition of Nanobiofertilizer -- Mechanisms of Nutrient Delivery and Enhanced Bioavailability -- Seed Priming (Nanopriming) -- Soil-Based Application -- Nanobiofertilizer Plant System Interaction -- Impact of Nanobiofertilizer on Plant Biomass -- Factors Contributing to Enhanced Plant Growth -- Comparison of Biomass Enhancement with Traditional Fertilizers -- Nanobiofertilizer-Induced Biomass and Chlorophyll Content Enhancement -- Crop-Specific Responses to Nanobiofertilizers -- Case Studies Highlighting Positive Outcomes on Various Crops -- Environmental and Economic Considerations on the Use of Nanobiofertilizers -- Comparison of Nanobiofertilizers with Traditional Fertilizers in Terms of Cost and Effectiveness.
Potential Long-Term Benefits for Soil Health and Ecosystem -- Addressing Concerns Related to Nanoparticle Toxicity and Accumulation -- Need for Standardized Testing Protocols and Safety Assessments -- Exploration of Innovative Nanobiofertilizer Formulations and Delivery Methods -- Strategies for Incorporating Nanobiofertilizers into Existing Farming Systems -- Synergistic Effects of Combining Nanobiofertilizers with Other Sustainable Practices -- Practical Considerations for Large-Scale Implementation -- Potential to Revolutionize Agriculture and Contribute to Food Security -- Call to Action for Continued Research, Development, and Adoption of Nanobiofertilizers -- Conclusion -- References -- Chapter 3 Effect of Bionanofertilizer on Proximate Composition of Crops -- 3.1 Introduction -- 3.2 Biological Synthesis of Nanofertilizers -- 3.2.1 Bacterial-Based Nanosynthesis -- 3.2.2 Fungal-Based Nanosynthesis -- 3.2.3 Algal-Based Nanosynthesis -- 3.2.4 Plant-Based Nanosynthesis -- 3.3 Composition of Bionanofertilizers -- 3.3.1 Macronutrient Bionanofertilizer -- 3.3.2 Micronutrient Bionanofertilizer -- 3.3.3 Hybrid Bionanofertilizers -- 3.4 Properties of Bionanofertilizers -- 3.4.1 Efficient Nutrient Release and Use -- 3.4.2 Maintenance of Equilibrium Between Nutrient Demand and Nutrient Supply -- 3.4.3 Enhancement of Soil Heterogeneity and Reduction of Environmental Pollution -- 3.4.4 Improvement of Soil Water Retention Capacity -- 3.5 Effect of Bionanofertilizers of Proximate Parameters of Crops -- 3.6 Conclusion and Future Direction -- References -- Chapter 4 The Role of Policy Maker, Relevant Stakeholders and Government Agency in Translating Nanobiofertilizer Research into Policy -- 4.1 Introduction -- 4.2 Views of the Dangers of Nanotechnology and Confidence in Stakeholders -- 4.3 Policy Making Process. 4.4 Benefits of Agencies in the Nanoproduction of Fertilizer -- 4.5 Relevant Stakeholders in the Implementation of Policy -- 4.6 Report of Nanobiofertilizers Worldwide -- 4.7 Government Agencies and Their Impact -- 4.8 Translating Research Into Policy -- 4.9 Global Safety and Legal Framework for Agricultural Goods Based on Nanotechnology -- 4.10 Future Initiatives and Studies to Support the Development of Nanobiofertilizers -- Conclusion -- References -- Chapter 5 Structural Elucidation, Detection, and Characterization of Essential Nutrients Necessary for Soil Fertilization -- 5.1 Introduction -- 5.1.1 Importance of Soil Fertility in Agriculture -- 5.1.2 Role of Essential Nutrients in Soil Fertilization -- 5.2 Nitrogen (N) in Soil Fertilization -- 5.2.1 Significance of Nitrogen for Plant Growth -- 5.2.2 Structural Elucidation of Nitrogen Compounds -- 5.3 Phosphorus (P) in Soil Fertilization -- 5.3.1 Importance of Phosphorus in Plant Growth -- 5.3.2 Structural Elucidation of Phosphorus Compounds -- 5.4 Potassium (K) in Soil Fertilization -- 5.4.1 Role of Potassium in Plant Nutrition -- 5.4.2 Characterization of Potassium in Soils -- 5.5 Optimization of Nutrient Management Strategies -- 5.5.1 Integration of Nutrient Detection and Characterization Data -- 5.5.2 Targeted and Efficient Fertilization Approaches -- Conclusion -- References -- Chapter 6 Effect of Nanobiofertilizer on Phytochemicals -- 6.1 General Overview on Nanobiofertilizer -- 6.2 Constituents of Nanobiofertilizer -- 6.2.1 Nanoparticles -- 6.2.1.1 Zinc Nanoparticles or ZnNPs -- 6.2.1.2 Silver Nanoparticles or AgNPS -- 6.2.1.3 Silicon Nanoparticles or SiNPs -- 6.2.1.4 Copper Nanoparticles or CuNPs -- 6.2.2 Biofertilizer -- 6.2.3 Preparation of Nanobiofertilizer -- 6.2 Concept of Nanobiofertilizers and Their Potential as a Sustainable Alternative to Conventional Fertilizers. 6.3 Importance of Phytochemicals in Plant Growth and Human Health -- 6.3.1 Phytochemical Research -- 6.4 Mechanisms of Nanobiofertilizer on Phytochemicals -- 6.4.1 Mechanism of Action of NFs -- 6.4.2 Mode of Application of NFs -- 6.4.3 Roots -- 6.5 Recent Studies on Effect of Nanobiofertilizer on Phytochemicals -- 6.6 Conclusion and Future Trends on Nanobiofertilizer on Phytochemicals -- References -- Chapter 7 Characterization of Nanoparticles Used as Nanobiofertilizers -- 7.1 Introduction -- 7.2 Some Spectroscopic Characterization Technique for Nanomaterials -- 7.2.1 X-Ray Diffraction (XRD) -- 7.2.2 Principle of X-Ray Diffraction (XRD) -- 7.2.3 Ultraviolet-Visible Spectroscopy (UV-vis) -- 7.2.4 Scanning Electron Microscopy (SEM) -- 7.2.5 Zeta Potential Measurements (ZPM) -- 7.2.6 Principle of Zeta Potential Measurements (ZPM) -- 7.2.7 Dital Polarimeter -- 7.2.8 Dynamic Light Scattering (DSL) -- 7.2.8.1 Principle of Dynamic Light Scattering (DSL) -- 7.2.9 Transform Infrared (FTIR) Spectroscopy -- 7.2.9.1 Principle of Transform Infrared (FTIR) Spectroscopy -- 7.3 Characterization of Nanobiofertilizer Through Chemical and Biological Synthesis -- 7.4 Application of Nanobiofertilizer -- 7.5 Environmental Impact Assessment -- 7.6 Future Perspectives and Challenges -- 7.6.1 Future Perspectives -- 7.6.2 Challenges -- 7.7 Conclusion -- References -- Chapter 8 Toxicological Effects of Nanobiofertilizer on Water Body, Water Quality, Lower Plants, Zooplanktons, and Beneficial Microorganisms -- 8.1 Introduction -- 8.2 Effects of Nanofertilizer on Soil Microbial Community -- 8.3 Nanofertilizers Versus Biofertilizers: Dissimilarity in Synthesis -- 8.4 Nanobiofertilizer -- 8.4.1 Toxicological Effects of Nanobiofertilizer on Water Body and Water Quality -- 8.4.2 Effects of Nanobiofertilizer on Lower Plants -- 8.4.3 Effects of Nanobiofertilizer on Zooplanktons. 8.4.4 Toxicological Effects of Nanobiofertilizer on Beneficial Microorganisms -- 8.5 Conclusion -- References -- Chapter 9 Various Techniques Used in the Application of Nanobiofertilizers on Crops After Synthesis -- 9.1 Introduction -- 9.2 Synthesis of Nanoparticles -- 9.2.1 Microbial Synthesis of Nanomaterials -- 9.2.2 Plant-Mediated Synthesis of Nanoparticles -- 9.3 Synthesis of Nanobiofertilizers -- 9.4 Methods Used in the Application of Nanobiofertilizers on Crops -- 9.4.1 Foliar Spraying -- 9.4.2 Seed Nanopriming -- 9.4.3 Soil Treatment -- 9.5 Conclusion -- References -- Chapter 10 Non-Target Effect, Environmental Impact, and Assessment of Nanobiofertilizer -- 10.1 Introduction -- 10.2 Environmental Impact of Nanobiofertilizer on Soil Properties -- 10.3 Non-Targeted Effects on Soil Properties -- 10.3.1 Physicochemical Properties of Soil -- 10.3.2 Biological Properties of Soil -- Soil Carbon and Carbon Sequestration -- Soil Respiration -- Soil Enzymes -- Soil Microorganisms and Microbial Diversity -- 10.4 Recommendation and Conclusion -- References -- Chapter 11 Reported Genes Regulating the Biological Activities in Microorganisms Used in the Formation of Nanobiofertilizers -- 11.1 Introduction -- 11.2 Synthesis of Nanoparticles -- 11.2.1 Biosynthesis of Nanoparticles -- 11.2.2 Microorganisms Used for the Synthesis of Nanobiofertilizers -- 11.3 Genes Regulating the Biological Activities in Plant Growth-Promoting Rhizobacteria -- 11.4 Conclusion -- References -- Chapter 12 Relevance of Molecular Genetics and Synthetic Biology Involved in the Characterization of Microorganisms Used in Nanofertilizer Research -- 12.1 Introduction -- 12.2 Molecular Genetics and Synthetic Biology -- 12.2.1 Molecular Genetics -- 12.2.2 Synthetic Biology -- 12.2.2.1 Synthetic Biology Tools for Engineering Nanobiofertilizer Microorganisms. 12.2.2.2 Case Studies on Use of Synthetic Biology to Enhance Microorganisms for Nanobiofertilizers. |
| Record Nr. | UNINA-9910902900303321 |
Adetunji Charles Oluwaseun
|
||
| Newark : , : John Wiley & Sons, Incorporated, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje
| Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] |
| Descrizione fisica | 1 online resource (624 pages) |
| Disciplina | 616.9883 |
| Soggetto topico |
Tropical medicine
Phytochemicals - Therapeutic use |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-119-61715-4
1-119-61714-6 1-119-61711-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- Part I Introduction to Neglected Tropical Diseases -- Chapter 1 Epidemiology of Neglected Tropical Diseases -- List of Abbreviations -- 1.1 Introduction -- 1.2 Protozoan Infections -- 1.2.1 Human African Trypanosomiasis -- 1.2.2 Chagas Disease (American Trypanosomiasis) -- 1.2.3 Leishmaniasis -- 1.2.4 Amoebiasis -- 1.3 Helminth Infections -- 1.3.1 Soil-Transmitted Helminthiasis Infections -- 1.3.2 Schistosomiasis -- 1.3.3 Echinococcosis -- 1.3.4 Lymphatic Filariasis -- 1.3.5 Onchocerciasis ("River Blindness") -- 1.3.6 Foodborne Trematodiases -- 1.3.7 Dracunculiasis (Also Called Guinea Worm Disease) -- 1.4 Bacterial Infections -- 1.4.1 Yaws -- 1.4.2 Trachoma -- 1.4.3 Leprosy -- 1.4.4 Buruli Ulcer -- 1.5 Viral Infections -- 1.5.1 Rabies -- 1.5.2 Dengue -- 1.5.3 Chikungunya -- 1.6 Fungal and Ectoparasitic Infections -- 1.6.1 Chromoblastomycosis, Mycetoma/Eumycetoma, and Other Deep Mycoses -- 1.6.2 Scabies -- 1.6.3 Myiasis -- 1.7 Future Direction -- 1.8 Conclusion -- Acknowledgments -- References -- Chapter 2 Neglected Tropical Diseases, Phytochemicals, Protein Targets, and Mechanisms in Drug Discovery -- List of Abbreviations -- 2.1 Introduction -- 2.2 African Trypanosomiasis -- 2.2.1 Phytochemicals Against African Trypanosomiasis -- 2.3 Buruli Ulcer -- 2.3.1 Phytochemicals Against Buruli Ulcer -- 2.4 Chagas Disease -- 2.4.1 Phytochemicals Against Chagas Disease -- 2.5 Chikungunya -- 2.5.1 Phytochemicals Against Chikungunya -- 2.6 Dengue -- 2.6.1 Phytochemicals Against Dengue -- 2.7 Leishmaniasis -- 2.7.1 Phytochemicals Against Leishmaniasis -- 2.8 Leprosy -- 2.8.1 Indeterminate Leprosy -- 2.8.2 Phytochemicals Against Leprosy -- 2.9 Lymphatic Filariasis -- 2.9.1 Phytochemicals Against Lymphatic Filariasis -- 2.10 Mycetoma -- 2.10.1 Phytochemicals Against Mycetoma.
2.11 Onchocerciasis -- 2.11.1 Phytochemicals Against Onchocerciasis -- 2.12 Rabies -- 2.12.1 Phytochemicals Against Rabies -- 2.13 Scabies -- 2.13.1 Phytochemicals Against Scabies -- 2.14 Schistosomiasis -- 2.14.1 Phytochemicals Against Schistosomiasis -- 2.15 Conclusion -- References -- Chapter 3 Novel Bioactive Lead Compounds for Drug Discovery Against Neglected Tropical Diseases, Leishmaniasis, Lymphatic Filariasis, Trypanosomiasis (African Sleeping Sickness and Chagas Disease), and Schistosomiasis -- List of Abbreviations/Definitions -- 3.1 Introduction -- 3.2 Prevalence of Neglected Tropical Diseases -- 3.2.1 Leishmaniasis -- 3.2.2 Lymphatic Filariasis -- 3.2.3 Trypanosomiasis -- 3.2.3.1 African Trypanosomiasis (African Sleeping Sickness) -- 3.2.3.2 American Trypanosomiasis (Chagas Disease) -- 3.2.4 Schistosomiasis -- 3.3 Novel, Economical, and Efficacious Therapeutics from Medicinal Plants Against NTDs -- 3.3.1 Phytochemicals Effective Against Leishmania Parasite -- 3.3.2 Plants and Phytochemicals Effective Against Filarial Parasite -- 3.3.3 Plants and Phytochemicals Effective Against Trypanosomasis -- 3.3.4 Plants and Phytochemicals Effective Against Schistosomiasis -- 3.4 Future Prospects -- 3.5 Conclusion -- References -- Part II Protozoan Infections -- Chapter 4 Herbal, Nutritional, and Traditional Remedies for Giardiasis: Phytochemicals as Drug Candidates -- List of Abbreviations -- 4.1 Introduction -- 4.1.1 Epidemiology and Symptoms of Giardiasis -- 4.1.2 Life Cycle of G. duodenalis -- 4.1.3 Pathophysiology of Giardial Infection -- 4.1.4 Resistance to Allopathic Drug and Relevance of Herbal Medication -- 4.2 Plant-Based Dietary Supplements for Giardiasis Management -- 4.2.1 Oligosaccharide and Disaccharidase Supplementation -- 4.2.2 Dietary Fiber-Enriched Food -- 4.2.3 Agglutinin from Wheat -- 4.2.4 Vitamin and Mineral Supplements. 4.2.4.1 Vitamin A Supplementation -- 4.2.4.2 Compensation of Vitamin B12 -- 4.2.4.3 Zinc Status Management -- 4.2.5 Fermented Vegetables as Probiotic Source -- 4.2.6 Phenolic Compound Enriched Plant Food -- 4.3 Traditional Treatment of Giardiasis with Herbal Ethnomedicine -- 4.3.1 Hints of Antiprotozoal Medicines from Ancient Communities -- 4.3.2 Domestic Remedies and Alternative Medicine for Giardiasis -- 4.3.3 Applied Spectrum of Ethnopharmacology in Different Continents -- 4.3.3.1 Asian Medicinal Extracts -- 4.3.3.2 African Traditional Medicines -- 4.3.3.3 South American Ethnomedicine -- 4.4 Phytochemical Candidates for Advanced Giardicidal Drug Development -- 4.4.1 Terpenoids -- 4.4.2 Aromatic Ether -- 4.4.3 Alkaloids -- 4.4.4 Organo-sulfur Compounds -- 4.4.5 Lipids and Steroids -- 4.4.6 Phenolic Compounds -- 4.5 Future Prospects -- 4.5.1 Extension of Medicinal Compound Screening -- 4.5.2 Methodical Studies on Toxicology and Drug Adversity -- 4.5.3 Correlation of Herbal Drugs with Molecular Targets of Giardia -- 4.6 Summary, Prospects, and Conclusion -- References -- Chapter 5 Antiprotozoal Activity of Phytochemicals Against Entamoeba histolytica, the Causative Agent of Amoebiasis -- List of Abbreviations -- 5.1 Introduction -- 5.2 Life Cycle of Entamoeba histolytica -- 5.3 Diagnostic Techniques for Identification of E. histolytica -- 5.3.1 Intestinal Amoebiasis -- 5.3.1.1 Microscopy -- 5.3.1.2 Culture and Isoenzyme Analysis -- 5.3.1.3 Antigen Detection Test -- 5.3.1.4 Molecular-Based Test -- 5.3.1.5 Point-of-Care (POC) Test -- 5.4 Treatment of Amoebiasis -- 5.5 Alternative Treatment for Amoebiasis -- 5.6 Chemical Structure of Phytochemicals Effective Against E. histolytica -- 5.7 Possible Mechanisms of Phytochemicals as Antiamoebic -- 5.8 Future Projections -- 5.9 Conclusion -- References -- Chapter 6 Antileishmanial Potentials of Phytochemicals. 6.1 Introduction -- 6.2 Antileishmanial Activity of Propolis -- 6.2.1 Propolis from Turkey -- 6.2.2 Propolis from Brazil -- 6.2.3 Propolis from Portugal -- 6.2.4 Propolis from Cuba -- 6.2.5 Propolis from Ecuador -- 6.3 Antileishmanial Activity of Wild Mushrooms -- 6.4 Antileishmanial Activity of Medicinal Plants from Various Flora -- 6.4.1 Peruvian Flora -- 6.4.2 Ecuadorean Flora -- 6.4.3 Mexican Flora -- 6.4.4 Bolivian Flora -- 6.4.5 Iranian Flora -- 6.5 Antileishmanial Activity of Chemical Constituents -- 6.5.1 Alkaloids -- 6.5.2 Flavonoids -- 6.5.3 Terpenes -- 6.5.4 Glycoglycerolipids -- 6.5.5 Guttiferone A as a Lead Compound for Semisynthesis of Antileishmanial Molecules -- 6.6 Conclusion -- References -- Part III Helminth Infections -- Chapter 7 Prospects of Phytochemicals for the Treatment of Helminthiasis -- List of Abbreviations -- 7.1 Introduction -- 7.1.1 History -- 7.1.2 Prevalence -- 7.2 Molecular Characteristics of Soil-transmitted Helminthiasis -- 7.3 Clinical Features and Pathogenesis -- 7.4 Prevention -- 7.5 Treatment -- 7.6 Plants and Phytochemicals with Anthelmintic Activities -- 7.6.1 Modes of Action of Phytochemical Against the Soil-transmitted Helminthiasis -- 7.7 Scientific Reports of Medicinal Plants with Anthelmintic Properties -- 7.7.1 Adhatoda vasica -- 7.7.2 Allium sativum -- 7.7.3 Baliospermum montanum Muell -- 7.7.4 Butea monosperma -- 7.7.5 Calotropis procera -- 7.7.6 Carica papaya -- 7.7.7 Ficus benghalensis -- 7.7.8 Mimosa pudica -- 7.7.9 Punica granatum -- 7.7.10 Verbascum thapsus -- 7.7.11 Zingiber officinale -- 7.8 Future Prospects -- 7.9 Conclusion -- References -- Chapter 8 Efficacy of Phytochemicals of Medicinal Plants for the Treatment of Human Echinococcosis: Echinococcal Disease, Hydatidosis, or Hydatid Disease Drug Discovery -- List of Abbreviations -- 8.1 Introduction -- 8.2 Molecular Analysis. 8.3 Life Cycle of Echinococcosis -- 8.4 Previous Studies on the Positive Effects of Medicinal Plants and Phytochemicals -- 8.4.1 In vitro and in vivo Effect of Phytochemicals Against Echinococcus Infection -- 8.5 Synthetic Drugs Previously Used for Management of Echinococcosis Disease -- 8.6 Conclusion and Future Prospects -- References -- Chapter 9 Filaricidal Activity of Phytochemicals Against Lymphatic Filariasis -- List of Abbreviations -- 9.1 Introduction -- 9.2 Life Cycle of the Parasite -- 9.3 Synthetic Drugs Used for Treatment of Lymphatic Filariasis -- 9.4 Phytochemicals Used for the Treatment of Lymphatic Filariasis -- 9.4.1 Acacia auriculiformis -- 9.4.2 Aegle marmelos -- 9.4.3 Alnus nepalensis -- 9.4.4 Andrographis paniculata -- 9.4.5 Azadirachta indica -- 9.4.6 Bauhinia racemosa -- 9.4.7 Butea monosperma -- 9.4.8 Caesalpinia bonducella -- 9.4.9 Cardiospermum halicacabum -- 9.4.10 Centratherum anthelminticum -- 9.4.11 Excoecaria agallocha -- 9.4.12 Ficus racemosa -- 9.4.13 Glycyrrhiza glabra -- 9.4.14 Hibiscus sabdariffa -- 9.4.15 Lantana camara -- 9.4.16 Leucas cephalotes -- 9.4.17 Mallotus philippensis -- 9.4.18 Morinda citrifolia -- 9.4.19 Moringa oleifera -- 9.4.20 Plumbago indica -- 9.4.21 Pongamia pinnata -- 9.4.22 Psoralea corylifolia -- 9.4.23 Ricinus communis -- 9.4.24 Saxifraga stracheyion -- 9.4.25 Sphaeranthus indicus -- 9.4.26 Streblus asper -- 9.4.27 Trachyspermum ammi -- 9.4.28 Vitex negundo -- 9.4.29 Xylocarpus granatum -- 9.4.30 Zingiber officinale -- 9.5 Future Perspective -- 9.6 Conclusion -- References -- Chapter 10 Dracunculiasis (Guinea Worm Disease) and Phytochemicals in Drug Discovery -- List of Abbreviations -- 10.1 Introduction -- 10.2 Historical Insights of Dracunculiasis -- 10.3 Prevalence, Burden, and Distribution of Disease -- 10.4 Life Cycle, Pathogenesis, and Clinical Manifestations of Dracunculiasis. 10.5 Prevention and Eradication of Disease. |
| Record Nr. | UNINA-9910555163203321 |
| Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje
| Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] |
| Descrizione fisica | 1 online resource (624 pages) |
| Disciplina | 616.9883 |
| Soggetto topico |
Tropical medicine
Phytochemicals - Therapeutic use |
| ISBN |
1-119-61715-4
1-119-61714-6 1-119-61711-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- Part I Introduction to Neglected Tropical Diseases -- Chapter 1 Epidemiology of Neglected Tropical Diseases -- List of Abbreviations -- 1.1 Introduction -- 1.2 Protozoan Infections -- 1.2.1 Human African Trypanosomiasis -- 1.2.2 Chagas Disease (American Trypanosomiasis) -- 1.2.3 Leishmaniasis -- 1.2.4 Amoebiasis -- 1.3 Helminth Infections -- 1.3.1 Soil-Transmitted Helminthiasis Infections -- 1.3.2 Schistosomiasis -- 1.3.3 Echinococcosis -- 1.3.4 Lymphatic Filariasis -- 1.3.5 Onchocerciasis ("River Blindness") -- 1.3.6 Foodborne Trematodiases -- 1.3.7 Dracunculiasis (Also Called Guinea Worm Disease) -- 1.4 Bacterial Infections -- 1.4.1 Yaws -- 1.4.2 Trachoma -- 1.4.3 Leprosy -- 1.4.4 Buruli Ulcer -- 1.5 Viral Infections -- 1.5.1 Rabies -- 1.5.2 Dengue -- 1.5.3 Chikungunya -- 1.6 Fungal and Ectoparasitic Infections -- 1.6.1 Chromoblastomycosis, Mycetoma/Eumycetoma, and Other Deep Mycoses -- 1.6.2 Scabies -- 1.6.3 Myiasis -- 1.7 Future Direction -- 1.8 Conclusion -- Acknowledgments -- References -- Chapter 2 Neglected Tropical Diseases, Phytochemicals, Protein Targets, and Mechanisms in Drug Discovery -- List of Abbreviations -- 2.1 Introduction -- 2.2 African Trypanosomiasis -- 2.2.1 Phytochemicals Against African Trypanosomiasis -- 2.3 Buruli Ulcer -- 2.3.1 Phytochemicals Against Buruli Ulcer -- 2.4 Chagas Disease -- 2.4.1 Phytochemicals Against Chagas Disease -- 2.5 Chikungunya -- 2.5.1 Phytochemicals Against Chikungunya -- 2.6 Dengue -- 2.6.1 Phytochemicals Against Dengue -- 2.7 Leishmaniasis -- 2.7.1 Phytochemicals Against Leishmaniasis -- 2.8 Leprosy -- 2.8.1 Indeterminate Leprosy -- 2.8.2 Phytochemicals Against Leprosy -- 2.9 Lymphatic Filariasis -- 2.9.1 Phytochemicals Against Lymphatic Filariasis -- 2.10 Mycetoma -- 2.10.1 Phytochemicals Against Mycetoma.
2.11 Onchocerciasis -- 2.11.1 Phytochemicals Against Onchocerciasis -- 2.12 Rabies -- 2.12.1 Phytochemicals Against Rabies -- 2.13 Scabies -- 2.13.1 Phytochemicals Against Scabies -- 2.14 Schistosomiasis -- 2.14.1 Phytochemicals Against Schistosomiasis -- 2.15 Conclusion -- References -- Chapter 3 Novel Bioactive Lead Compounds for Drug Discovery Against Neglected Tropical Diseases, Leishmaniasis, Lymphatic Filariasis, Trypanosomiasis (African Sleeping Sickness and Chagas Disease), and Schistosomiasis -- List of Abbreviations/Definitions -- 3.1 Introduction -- 3.2 Prevalence of Neglected Tropical Diseases -- 3.2.1 Leishmaniasis -- 3.2.2 Lymphatic Filariasis -- 3.2.3 Trypanosomiasis -- 3.2.3.1 African Trypanosomiasis (African Sleeping Sickness) -- 3.2.3.2 American Trypanosomiasis (Chagas Disease) -- 3.2.4 Schistosomiasis -- 3.3 Novel, Economical, and Efficacious Therapeutics from Medicinal Plants Against NTDs -- 3.3.1 Phytochemicals Effective Against Leishmania Parasite -- 3.3.2 Plants and Phytochemicals Effective Against Filarial Parasite -- 3.3.3 Plants and Phytochemicals Effective Against Trypanosomasis -- 3.3.4 Plants and Phytochemicals Effective Against Schistosomiasis -- 3.4 Future Prospects -- 3.5 Conclusion -- References -- Part II Protozoan Infections -- Chapter 4 Herbal, Nutritional, and Traditional Remedies for Giardiasis: Phytochemicals as Drug Candidates -- List of Abbreviations -- 4.1 Introduction -- 4.1.1 Epidemiology and Symptoms of Giardiasis -- 4.1.2 Life Cycle of G. duodenalis -- 4.1.3 Pathophysiology of Giardial Infection -- 4.1.4 Resistance to Allopathic Drug and Relevance of Herbal Medication -- 4.2 Plant-Based Dietary Supplements for Giardiasis Management -- 4.2.1 Oligosaccharide and Disaccharidase Supplementation -- 4.2.2 Dietary Fiber-Enriched Food -- 4.2.3 Agglutinin from Wheat -- 4.2.4 Vitamin and Mineral Supplements. 4.2.4.1 Vitamin A Supplementation -- 4.2.4.2 Compensation of Vitamin B12 -- 4.2.4.3 Zinc Status Management -- 4.2.5 Fermented Vegetables as Probiotic Source -- 4.2.6 Phenolic Compound Enriched Plant Food -- 4.3 Traditional Treatment of Giardiasis with Herbal Ethnomedicine -- 4.3.1 Hints of Antiprotozoal Medicines from Ancient Communities -- 4.3.2 Domestic Remedies and Alternative Medicine for Giardiasis -- 4.3.3 Applied Spectrum of Ethnopharmacology in Different Continents -- 4.3.3.1 Asian Medicinal Extracts -- 4.3.3.2 African Traditional Medicines -- 4.3.3.3 South American Ethnomedicine -- 4.4 Phytochemical Candidates for Advanced Giardicidal Drug Development -- 4.4.1 Terpenoids -- 4.4.2 Aromatic Ether -- 4.4.3 Alkaloids -- 4.4.4 Organo-sulfur Compounds -- 4.4.5 Lipids and Steroids -- 4.4.6 Phenolic Compounds -- 4.5 Future Prospects -- 4.5.1 Extension of Medicinal Compound Screening -- 4.5.2 Methodical Studies on Toxicology and Drug Adversity -- 4.5.3 Correlation of Herbal Drugs with Molecular Targets of Giardia -- 4.6 Summary, Prospects, and Conclusion -- References -- Chapter 5 Antiprotozoal Activity of Phytochemicals Against Entamoeba histolytica, the Causative Agent of Amoebiasis -- List of Abbreviations -- 5.1 Introduction -- 5.2 Life Cycle of Entamoeba histolytica -- 5.3 Diagnostic Techniques for Identification of E. histolytica -- 5.3.1 Intestinal Amoebiasis -- 5.3.1.1 Microscopy -- 5.3.1.2 Culture and Isoenzyme Analysis -- 5.3.1.3 Antigen Detection Test -- 5.3.1.4 Molecular-Based Test -- 5.3.1.5 Point-of-Care (POC) Test -- 5.4 Treatment of Amoebiasis -- 5.5 Alternative Treatment for Amoebiasis -- 5.6 Chemical Structure of Phytochemicals Effective Against E. histolytica -- 5.7 Possible Mechanisms of Phytochemicals as Antiamoebic -- 5.8 Future Projections -- 5.9 Conclusion -- References -- Chapter 6 Antileishmanial Potentials of Phytochemicals. 6.1 Introduction -- 6.2 Antileishmanial Activity of Propolis -- 6.2.1 Propolis from Turkey -- 6.2.2 Propolis from Brazil -- 6.2.3 Propolis from Portugal -- 6.2.4 Propolis from Cuba -- 6.2.5 Propolis from Ecuador -- 6.3 Antileishmanial Activity of Wild Mushrooms -- 6.4 Antileishmanial Activity of Medicinal Plants from Various Flora -- 6.4.1 Peruvian Flora -- 6.4.2 Ecuadorean Flora -- 6.4.3 Mexican Flora -- 6.4.4 Bolivian Flora -- 6.4.5 Iranian Flora -- 6.5 Antileishmanial Activity of Chemical Constituents -- 6.5.1 Alkaloids -- 6.5.2 Flavonoids -- 6.5.3 Terpenes -- 6.5.4 Glycoglycerolipids -- 6.5.5 Guttiferone A as a Lead Compound for Semisynthesis of Antileishmanial Molecules -- 6.6 Conclusion -- References -- Part III Helminth Infections -- Chapter 7 Prospects of Phytochemicals for the Treatment of Helminthiasis -- List of Abbreviations -- 7.1 Introduction -- 7.1.1 History -- 7.1.2 Prevalence -- 7.2 Molecular Characteristics of Soil-transmitted Helminthiasis -- 7.3 Clinical Features and Pathogenesis -- 7.4 Prevention -- 7.5 Treatment -- 7.6 Plants and Phytochemicals with Anthelmintic Activities -- 7.6.1 Modes of Action of Phytochemical Against the Soil-transmitted Helminthiasis -- 7.7 Scientific Reports of Medicinal Plants with Anthelmintic Properties -- 7.7.1 Adhatoda vasica -- 7.7.2 Allium sativum -- 7.7.3 Baliospermum montanum Muell -- 7.7.4 Butea monosperma -- 7.7.5 Calotropis procera -- 7.7.6 Carica papaya -- 7.7.7 Ficus benghalensis -- 7.7.8 Mimosa pudica -- 7.7.9 Punica granatum -- 7.7.10 Verbascum thapsus -- 7.7.11 Zingiber officinale -- 7.8 Future Prospects -- 7.9 Conclusion -- References -- Chapter 8 Efficacy of Phytochemicals of Medicinal Plants for the Treatment of Human Echinococcosis: Echinococcal Disease, Hydatidosis, or Hydatid Disease Drug Discovery -- List of Abbreviations -- 8.1 Introduction -- 8.2 Molecular Analysis. 8.3 Life Cycle of Echinococcosis -- 8.4 Previous Studies on the Positive Effects of Medicinal Plants and Phytochemicals -- 8.4.1 In vitro and in vivo Effect of Phytochemicals Against Echinococcus Infection -- 8.5 Synthetic Drugs Previously Used for Management of Echinococcosis Disease -- 8.6 Conclusion and Future Prospects -- References -- Chapter 9 Filaricidal Activity of Phytochemicals Against Lymphatic Filariasis -- List of Abbreviations -- 9.1 Introduction -- 9.2 Life Cycle of the Parasite -- 9.3 Synthetic Drugs Used for Treatment of Lymphatic Filariasis -- 9.4 Phytochemicals Used for the Treatment of Lymphatic Filariasis -- 9.4.1 Acacia auriculiformis -- 9.4.2 Aegle marmelos -- 9.4.3 Alnus nepalensis -- 9.4.4 Andrographis paniculata -- 9.4.5 Azadirachta indica -- 9.4.6 Bauhinia racemosa -- 9.4.7 Butea monosperma -- 9.4.8 Caesalpinia bonducella -- 9.4.9 Cardiospermum halicacabum -- 9.4.10 Centratherum anthelminticum -- 9.4.11 Excoecaria agallocha -- 9.4.12 Ficus racemosa -- 9.4.13 Glycyrrhiza glabra -- 9.4.14 Hibiscus sabdariffa -- 9.4.15 Lantana camara -- 9.4.16 Leucas cephalotes -- 9.4.17 Mallotus philippensis -- 9.4.18 Morinda citrifolia -- 9.4.19 Moringa oleifera -- 9.4.20 Plumbago indica -- 9.4.21 Pongamia pinnata -- 9.4.22 Psoralea corylifolia -- 9.4.23 Ricinus communis -- 9.4.24 Saxifraga stracheyion -- 9.4.25 Sphaeranthus indicus -- 9.4.26 Streblus asper -- 9.4.27 Trachyspermum ammi -- 9.4.28 Vitex negundo -- 9.4.29 Xylocarpus granatum -- 9.4.30 Zingiber officinale -- 9.5 Future Perspective -- 9.6 Conclusion -- References -- Chapter 10 Dracunculiasis (Guinea Worm Disease) and Phytochemicals in Drug Discovery -- List of Abbreviations -- 10.1 Introduction -- 10.2 Historical Insights of Dracunculiasis -- 10.3 Prevalence, Burden, and Distribution of Disease -- 10.4 Life Cycle, Pathogenesis, and Clinical Manifestations of Dracunculiasis. 10.5 Prevention and Eradication of Disease. |
| Record Nr. | UNINA-9910830428403321 |
| Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Phytochemical drug discovery for central nervous system disorders : biochemistry and therapeutic effects / / edited by Chukwuebuka Egbuna, Mithun Rudrapal
| Phytochemical drug discovery for central nervous system disorders : biochemistry and therapeutic effects / / edited by Chukwuebuka Egbuna, Mithun Rudrapal |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2023] |
| Descrizione fisica | 1 online resource (615 pages) |
| Disciplina | 737 |
| Soggetto topico | Central nervous system - Diseases |
| ISBN |
1-119-79411-0
1-119-79412-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Table of Contents -- Title Page -- Copyright Page -- Contributors -- Preface -- 1 Central Nervous System Disorders and Food and Drug Administration-Approved Drugs -- 1.1 Incidence and Prevalence of Major Neurologic Disorders -- 1.2 Etiology -- 1.3 Pathogenesis -- 1.4 Central Nervous System Disorders and Drugs Approved by the Food and Drug Administration -- 1.5 Conclusion -- References -- 2 Drug Discovery from Medicinal Plants against Parkinson's Disease -- 2.1 Pathogenesis of Parkinson's Disease -- 2.2 Natural Dopaminergic Neuroprotective Compounds -- 2.3 Nitrogenated Phytochemicals -- 2.4 Chinese Herbal Medications and Parkinson's Disease -- 2.5 Herbal Medicines from India and Parkinson's Disease -- 2.6 European Plants -- 2.7 α‐Synuclein as a Potential Therapeutic Target -- 2.8 Conclusion -- References -- 3 Drug Discovery from Medicinal Plants against Alzheimer's Disease -- 3.1 Pathogenesis -- 3.2 Treatment Strategies for Alzheimer's Disease -- 3.3 Medicinal Plants Having Effects against Alzheimer's Disease -- 3.4 Natural Products with Proven Anti‐Alzheimer's Activity -- 3.5 Conclusion -- References -- 4 Effects of Medicinal Plants and Phytochemicals on Schizophrenia -- 4.1 Mechanisms of Action Related to Schizophrenia -- 4.2 Ayurvedic Plants Used as Treatment for Schizophrenia and Related Psychoses -- 4.3 Conclusion -- References -- 5 Drug Discovery from Medicinal Plants and Phytochemicals against Neuropathic Pain -- 5.1 Mechanisms of Neuropathic Pain -- 5.2 Animal Models for Studying Neuropathic Pain -- 5.3 Medicinal Plants and Phytochemicals against Neuropathic Pain -- 5.4 Role of Plants and Phytochemicals in Different Neuropathic Pain Models -- 5.5 Future Perspectives -- 5.6 Conclusion -- References -- 6 Brain Function, Stroke, and Medicinal Herbs -- 6.1 Brain Function and Stroke -- 6.2 Strategies for Treatment of Ischemic Stroke.
6.3 Medicinal Plants for the Treatment of Stroke -- 6.4 Natural Products for the Treatment of Stroke -- 6.5 Recent Applications of Nanomedicine for Treatment of Stroke -- 6.6 Conclusion -- References -- 7 Plant‐Based Analgesics -- 7.1 Current Analgesic Drugs and Their Mechanisms of Action -- 7.2 Plant‐Derived Lead Compounds with Analgesic Activities -- 7.3 Analgesic Effects of Medicinal Plants Found in Nigeria -- 7.4 Limitations of Plant‐Based Analgesics -- 7.5 Future Directions and Perspective for Plant‐Based Analgesics -- 7.6 Conclusion -- References -- 8 Medicinal Plants and Phytochemicals against Depression -- 8.1 Causes of Depression -- 8.2 Symptoms of Depression -- 8.3 Diagnosis of Depression -- 8.4 Types of Depression -- 8.5 Treatment of Depression -- 8.6 Conclusion -- References -- 9 Anti‐inflammatory Agents from Medicinal Plants -- 9.1 Role of Neuroinflammation in Neurodegenerative Diseases -- 9.2 Neuroinflammatory Drugs -- 9.3 Medicinal Plants as Sources of Anti‐inflammatory Agents -- 9.4 Bioactive Compounds as Anti‐inflammatory Agents -- 9.5 Conclusion -- References -- 10 Plant‐Based Products and Phytochemicals against Viral Infections of the Central Nervous System -- 10.1 Viral Infections of the Central Nervous System -- 10.2 Plant and Phytochemicals as Antiviral Agents for Central Nervous System Viral Infections -- 10.3 Controlling Vectors of Viral Diseases of the Central Nervous System -- 10.4 Future Perspectives -- 10.5 Conclusion -- References -- 11 Fruits and Nutraceuticals for the Prevention and Treatment of Central Nervous System Disorders -- 11.1 Fruits for Cognition and Brain Health -- 11.2 Nutraceuticals in Ameliorating Neurodegeneration -- 11.3 Nutraceuticals in Alzheimer's Disease -- 11.4 Nutraceuticals in Parkinson's Disease -- 11.5 Nutraceuticals in Depression -- 11.6 Nutraceuticals in Psychotic Disorders -- 11.7 Conclusion. References -- 12 Neurorestorative Potential of Medicinal Plants and Their Phytochemicals -- 12.1 Therapeutic Value of Some Medicinal Plants and their Importance -- 12.2 Types of Medicinal Plants and Their Uses -- 12.3 Phytochemicals -- 12.4 Phytochemical Constituents in Some Medicinal Plants -- 12.5 The Brain -- 12.6 Brain Conditions -- 12.7 Protective Effects of Medicinal Plants on the Brain -- 12.8 Conclusion -- References -- 13 Neurotransmitter Modulation by Phytochemicals -- 13.1 Sources, Structures, and Classifications of Phytochemicals -- 13.2 Neurotransmitters and Their Functions -- 13.3 Modulation of Cholinergic Signaling by Phytochemicals -- 13.4 Effect of Phytochemicals on GABAergic Signaling -- 13.5 Effect of Phytochemicals on Glutamatergic Signaling -- 13.6 Modulation of Serotonergic and Dopaminergic Signaling by Phytochemicals -- 13.7 Conclusion -- Acknowledgments -- References -- 14 Antipyretic Agents from Plant Origins -- 14.1 Pyrexia Development, Its Mechanisms, and the Roles of Plant Metabolites as Antipyretics -- 14.2 Antipyretic Agents of Plant Origin -- 14.3 Conclusion and Future Perspectives -- References -- 15 Medicinal Herbs against Central Nervous System Disorders -- 15.1 Medicinal Plants as Interventions for Central Nervous System Disorders -- 15.2 Some Medicinal Plants with Neuroprotective Action on Central Nervous System Disorders -- 15.3 Some Central Nervous System Disorders and Medicinal Plant Interventions -- 15.4 Some Mechanistic Actions of Medicinal Herbs against Central Nervous System Disorders -- 15.5 Conclusion -- References -- 16 Important Antihistaminic Plants and Their Potential Role in Health -- 16.1 Antihistaminic Plants -- 16.2 Bioactive Compounds with Antihistaminic Activities -- 16.3 Conclusion -- References -- 17 Effect of Plant‐Based Anticonvulsant Products and Phytochemicals. 17.1 Types of Epileptic Seizures -- 17.2 Basic Mechanisms of Epilepsy -- 17.3 Epilepsy and Oxidative Stress -- 17.4 Epilepsy and Inflammation -- 17.5 Tests for Seizure Induction -- 17.6 Medicinal Plants Used to Treat Epilepsy -- 17.7 Conclusion -- References -- 18 Application of Nanophytomedicine for the Treatment of Central Nervous System Disorders -- 18.1 Neurodegenerative Disease and the Blood-Brain Barrier -- 18.2 Nano Approaches to Central Nervous System Drug Delivery -- 18.3 Nanophytomedicine for Treatment of Central Nervous System Disorders -- 18.4 Challenges in Nanophytomedicine -- 18.5 Conclusion -- References -- Index -- End User License Agreement. |
| Record Nr. | UNINA-9910830955703321 |
| Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Phytochemistry: An in-silico and in-vitro Update : Advances in Phytochemical Research / / edited by Shashank Kumar, Chukwuebuka Egbuna
| Phytochemistry: An in-silico and in-vitro Update : Advances in Phytochemical Research / / edited by Shashank Kumar, Chukwuebuka Egbuna |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XII, 577 p. 127 illus., 84 illus. in color.) |
| Disciplina | 572.572 |
| Soggetto topico |
Plant biochemistry
Plant physiology Proteins Plant anatomy Plant development Plant Biochemistry Plant Physiology Receptors Plant Anatomy/Development |
| ISBN | 981-13-6920-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910350357303321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Poisonous plants and phytochemicals in drug discovery / / edited by Andrew G. Mtewa, Chukwuebuka Egbuna, G. M. Narasimha Rao
| Poisonous plants and phytochemicals in drug discovery / / edited by Andrew G. Mtewa, Chukwuebuka Egbuna, G. M. Narasimha Rao |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley, , [2021] |
| Descrizione fisica | 1 online resource (426 pages) |
| Disciplina | 572.2 |
| Soggetto topico |
Botanical chemistry
Poisonous plants - Toxicology |
| ISBN |
1-119-65027-5
1-119-65025-9 1-119-65003-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910555296903321 |
| Hoboken, NJ : , : Wiley, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
